Literature DB >> 11685647

Diagnostic criteria for primary osteoporosis: year 2000 revision.

H Orimo1, Y Hayashi, M Fukunaga, T Sone, S Fujiwara, M Shiraki, K Kushida, S Miyamoto, S Soen, J Nishimura, Y Oh-Hashi, T Hosoi, I Gorai, H Tanaka, T Igai, H Kishimoto.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11685647     DOI： 10.1007/s007740170001

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN： 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  211 in total

1.  Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment.

Authors:  Masataka Shiraki; Tatsuhiko Kuroda; Yumiko Shiraki; Shiro Tanaka; Tsuyoshi Higuchi; Mitsuru Saito
Journal:  J Bone Miner Metab       Date:  2010-05-11       Impact factor: 2.626

2.  Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.

Authors:  Jun Iwamoto; Mitsuyoshi Uzawa
Journal:  Clin Rheumatol       Date:  2014-11-01       Impact factor: 2.980

3.  Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational study.

Authors:  Masayuki Takakuwa; Jun Iwamoto; Masahisa Konishi; Qi Zhou; Koichi Itabashi
Journal:  J Bone Miner Metab       Date:  2010-06-09       Impact factor: 2.626

4.  Dental panoramic radiograph as a tool to detect postmenopausal women with low bone mineral density: untrained general dental practitioners' diagnostic performance.

Authors:  Takashi Nakamoto; Akira Taguchi; Masahiko Ohtsuka; Yoshikazu Suei; Minoru Fujita; Keiji Tanimoto; Mikio Tsuda; Mitsuhiro Sanada; Koso Ohama; Junichiro Takahashi; Madeleine Rohlin
Journal:  Osteoporos Int       Date:  2003-06-24       Impact factor: 4.507

5.  Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women.

Authors:  Fumihiro Omasu; Yoichi Ezura; Mitsuko Kajita; Ryota Ishida; Mina Kodaira; Hideo Yoshida; Takao Suzuki; Takayuki Hosoi; Satoshi Inoue; Masataka Shiraki; Hajime Orimo; Mitsuru Emi
Journal:  J Hum Genet       Date:  2003-06-06       Impact factor: 3.172

6.  Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.

Authors:  Masataka Shiraki; Akira Itabashi
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

7.  Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis.

Authors:  Xian-Ping Wu; Er-Yuan Liao; Hong Zhang; Peng-Fei Shan; Xing-Zhi Cao; Shi-Ping Liu
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

8.  Prevalence of knee pain, lumbar pain and its coexistence in Japanese men and women: The Longitudinal Cohorts of Motor System Organ (LOCOMO) study.

Authors:  Noriko Yoshimura; Toru Akune; Saeko Fujiwara; Yoko Shimizu; Hideyo Yoshida; Go Omori; Akihiro Sudo; Yuji Nishiwaki; Munehito Yoshida; Hiroshi Shimokata; Takao Suzuki; Shigeyuki Muraki; Hiroyuki Oka; Kozo Nakamura
Journal:  J Bone Miner Metab       Date:  2013-11-09       Impact factor: 2.626

9.  The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese patients with osteoporosis: interim report.

Authors:  Hitoshi Saito; Hiroyuki Kakihata; Yosuke Nishida; Sawako Yatomi; Shigeru Nihojima; Yumiko Kobayashi; Hidehiro Tabata; Makoto Nomura
Journal:  J Bone Miner Metab       Date:  2016-10-03       Impact factor: 2.626

10.  Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women.

Authors:  S Tanaka; T Kuroda; M Saito; M Shiraki
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.